Optimizing proton beam therapy with mathematical models

April 02, 2019

Particle beam therapy is increasingly being used to treat many types of cancer. It consists in subjecting tumours to beams of high-energy charged particles such as protons. Although more targeted than conventional radiotherapy using X-rays, this approach still damages surrounding normal tissue. To design the optimum treatment plan for each patient, it is essential to know the energy of the beam and its effect on tumour and normal tissue alike. In a recent study published in EPJ D, a group of researchers led by Ramin Abolfath at the University of Texas MD Anderson Cancer Center, Houston, Texas, USA, put forward a new mathematical model outlining the effects of these beam therapies on patients' tissues, based on new, more complex, parameters. Using these new models, clinicians should be able to predict the effect of proton beams on normal and tumour tissue more precisely, allowing them to prepare more effective treatment plans.

The therapeutic and toxic effects of a proton beam can both be described using a combination of two effects: first, the biological effect of the radiation; and second, the amount of energy the beam transfers to tissue per unit length travelled, referred to as linear energy transfer (LET).

For over half a century, clinicians have been basing treatment plans on standard radiobiological models. These involved just two parameters: alpha, which is proportional to LET; and beta, which is independent of LET.

In this new approach, the authors modelled the processes through which energy transfer from ionising radiation produces potentially lethal DNA damage on a microscopic scale. They then coupled it to models of the birth and death of cells in millimetre-scale colonies.

Abolfath and colleagues fitted their model to data on the response of lung cancer cells to therapeutic doses of proton beam irradiation, and found that the standard radiobiological models applied most poorly when the beam energy was low. They then used these findings to generate new models in which alpha and beta were replaced by more complex formulae, which are able to explain some observed anomalies in cell survival.
-end-
Reference

R. Abolfath, Y. Helo, L. Bronk, A. Carabe, D. Grosshans and R. Mohan (2019) Renormalization of radiobiological response functions by energy loss fluctuations and complexities in chromosome aberration induction: deactivation theory for proton therapy from cells to tumor control, European Physical Journal D 73: 64, DOI: 10.1140/epjd/e2019-90263-5

Springer

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.